September 2, 2020 NIAID Funding News
Read this full edition online at http://www.niaid.nih.gov/
Feature Articles
Writing a Winning Application—Outline Your Experiments
The experimental design—the nitty-gritty of what you will actually do—must enable you to achieve the Specific Aims you describe and test your hypothesis. Optimally, your experimental results should be able to prove or disprove your central hypothesis.
Opportunities and Resources
The intent of our notice of special interest (NOSI) is to augment NIAID-sponsored ongoing and planned clinical trials with investigator-initiated studies to evaluate novel therapeutics and vaccines against SARS-CoV-2/COVID-19.
NIH offers administrative supplements to support career development or first-time research project grant awardees hindered by critical life events so they can sustain their research and maintain progress toward independence.
If your organization can support a broad range of services critical for designing, developing, executing, and analyzing clinical research, check out three NIAID contract solicitations from our Division of Allergy, Immunology, and Transplantation.
This career development initiative aims to increase the number of highly skilled scientists using nonhuman primate models to address complex translational biomedical research designed to foster translation of outcomes into the clinic.
NIH amended a notice of special interest that provides supplements for biomedical research focused on women of understudied, underrepresented, and underreported populations to include topics related to SARS-CoV-2 and COVID-19.
In The News
Postdoctoral researchers, you may qualify for a temporary extension to your eligibility for NIAID Career Transition Awards (K22) and NIH or NIAID Pathway to Independence Awards (K99/R00).
Starting October 1, 2020, the Notice of Award will feature a new standardized first page that captures key award information in an intuitive and digitally accessible format.
Advice Corner
When you are submitting a new (A0) application following an unfunded resubmission (A1), keep in mind that the A0 must not reference any previous applications or reviews; otherwise, NIH will withdraw the application without reviewing it.
Reader Questions
New Funding Opportunities
- PAR-20-258, Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01, Independent Clinical Trial Not Allowed)
- Autoimmune Diseases Statistical and Clinical Coordinating Center
- Allergy and Asthma, Statistical and Clinical Coordinating Center
- Transplantation Statistical and Clinical Coordinating Center (T-SCCC)
Find other announcements at NIAID Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario